8-K
0000921582 false 0000921582 2022-06-09 2022-06-09 0000921582 dei:OtherAddressMember 2022-06-09 2022-06-09

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

June 9, 2022

Date of report (Date of earliest event reported)

 

 

IMAX Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Canada   001-35066   98-0140269

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

2525 Speakman Drive

Mississauga, Ontario, Canada L5K 1B1

(905403-6500

 

902 Broadway, Floor 20

New York, New York, USA 10010

(212) 821-0100

(Address of principal executive offices, zip code, telephone numbers)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Shares, no par value   IMAX   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.07

Submission of Matters to a Vote of Security Holders.

IMAX Corporation (the “Company”) held its 2022 Annual Meeting of Shareholders (the “Meeting”) on June 9, 2022.

Set forth below are the matters acted upon by the Company’s shareholders at the Meeting, and the final voting results on each such matter.

 

  1.

Election of Directors

Eric A. Demirian, Kevin Douglas, Richard L. Gelfond, David W. Leebron, Michael MacMillian, Steve Pamon, Dana Settle, and Darren Throop were elected as directors of the Company. Each director elected will hold office until the earlier of the close of the next annual meeting of shareholders in 2023, the election or appointment of his or her successor, or the date of his or her resignation or termination.

 

Director

   Votes For      Votes Withheld/Abstained      Broker Non-Votes  

Eric A. Demirian

     43,070,980        1,740,922        3,465,244  

Kevin Douglas

     30,652,101        14,159,801        3,465,244  

Richard L. Gelfond

     44,149,179        662,724        3,465,243  

David W. Leebron

     34,990,454        9,821,449        3,465,243  

Michael MacMillan

     43,676,654        1,135,249        3,465,243  

Steve Pamon

     43,712,891        1,099,011        3,465,244  

Dana Settle

     30,459,991        14,351,912        3,465,243  

Darren D. Throop

     25,103,050        19,708,853        3,465,243  

 

  2.

Appointment of Auditor

The shareholders approved the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors until the next annual meeting of shareholders in 2023, and shareholders authorized the directors to fix the independent auditors’ remuneration.

 

Votes For

 

Votes Against

 

Votes Withheld/Abstained

 

Broker Non-Votes

46,646,220

  1,622,756   8,168   2

 

  3.

Named Executive Officer Compensation (“Say-on-Pay”)

The shareholders did not approve the advisory vote on the compensation of the Company’s Named Executive Officers.

 

Votes For

 

Votes Against

 

Votes Withheld/Abstained

 

Broker Non-Votes

21,392,843

  22,542,950   876,108   3,465,245


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

IMAX Corporation

(Registrant)

Date: June 10, 2022

    By:  

/s/ Robert D. Lister

    Name:   Robert D. Lister
    Title:   Chief Legal Officer and Senior Executive Vice President
    By:  

/s/ Kenneth Weissman

    Name:   Kenneth Weissman
    Title:   Senior Vice President, Legal Affairs & Corporate Secretary